{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T10:22:32Z","timestamp":1793701352587,"version":"4.5.1"},"reference-count":83,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,29]],"date-time":"2024-09-29T00:00:00Z","timestamp":1727568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["SFB F73"],"award-info":[{"award-number":["SFB F73"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["F7301"],"award-info":[{"award-number":["F7301"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jhep.2024.09.037","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T14:46:49Z","timestamp":1727707609000},"page":"658-675","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Inhibition of ATGL alleviates MASH via impaired PPAR\u03b1 signalling that favours hydrophilic bile acid composition in mice"],"prefix":"10.1016","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4120-7441","authenticated-orcid":false,"given":"Emmanuel Dauda","family":"Dixon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5601-9830","authenticated-orcid":false,"given":"Thierry","family":"Claudel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander Daniel","family":"Nardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5724-7616","authenticated-orcid":false,"given":"Alessandra","family":"Riva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0636-1320","authenticated-orcid":false,"given":"Claudia Daniela","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1431-2270","authenticated-orcid":false,"given":"Veronika","family":"Mlitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Busslinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2750-006X","authenticated-orcid":false,"given":"Hubert","family":"Scharnagl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatjana","family":"Stojakovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Sen\u00e9ca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helga","family":"Hinteregger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gernot F.","family":"Grabner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmar","family":"Kratky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7034-2861","authenticated-orcid":false,"given":"Henkjan","family":"Verkade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guenter","family":"Haemmerle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1275-6425","authenticated-orcid":false,"given":"Michael","family":"Trauner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5700","key":"10.1016\/j.jhep.2024.09.037_bib1","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1126\/science.1100747","article-title":"Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase","volume":"306","author":"Zimmermann","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.jhep.2024.09.037_bib2","unstructured":"Rinella ME, Lazarus JV, Ratziu V, et al. A multi-society Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 9900: 10.1097\/HEP.0000000000000520."},{"issue":"9","key":"10.1016\/j.jhep.2024.09.037_bib3","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"The Lancet Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.jhep.2024.09.037_bib4","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/lt.20738","article-title":"Nonalcoholic fatty liver disease and liver transplantation","volume":"12","author":"Angulo","year":"2006","journal-title":"Liver Transplant"},{"issue":"6","key":"10.1016\/j.jhep.2024.09.037_bib5","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2309000","article-title":"A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis","volume":"390","author":"Harrison","year":"2024","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.jhep.2024.09.037_bib6","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S2213-8587(14)70032-4","article-title":"Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome","volume":"2","author":"Yki-J\u00e4rvinen","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5774","key":"10.1016\/j.jhep.2024.09.037_bib7","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1126\/science.1123965","article-title":"Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase","volume":"312","author":"Haemmerle","year":"2006","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.jhep.2024.09.037_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1194\/jlr.R800031-JLR200","article-title":"Adipose triglyceride lipase and the lipolytic catabolism of cellular fat stores","volume":"50","author":"Zechner","year":"2009","journal-title":"J Lipid Res"},{"issue":"11","key":"10.1016\/j.jhep.2024.09.037_bib9","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1038\/s42255-021-00493-6","article-title":"Lipolysis: cellular mechanisms for lipid mobilization from fat stores","volume":"3","author":"Grabner","year":"2021","journal-title":"Nat Metab"},{"issue":"5","key":"10.1016\/j.jhep.2024.09.037_bib10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.cmet.2006.03.005","article-title":"Adipose triglyceride lipase-mediated lipolysis of cellular fat stores is activated by CGI-58 and defective in Chanarin-Dorfman Syndrome","volume":"3","author":"Lass","year":"2006","journal-title":"Cell Metab"},{"issue":"6","key":"10.1016\/j.jhep.2024.09.037_bib11","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1002\/hep.30583","article-title":"PNPLA3, CGI-58, and inhibition of hepatic triglyceride hydrolysis in mice","volume":"69","author":"Wang","year":"2019","journal-title":"Hepatology"},{"issue":"52","key":"10.1016\/j.jhep.2024.09.037_bib12","doi-asserted-by":"crossref","first-page":"40236","DOI":"10.1074\/jbc.M608048200","article-title":"Adipose triglyceride lipase and hormone-sensitive lipase are the major enzymes in adipose tissue triacylglycerol catabolism","volume":"281","author":"Schweiger","year":"2006","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1016\/j.jhep.2024.09.037_bib13","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.bbadis.2014.02.012","article-title":"Role of adipose tissue in methionine-choline-deficient model of non-alcoholic steatohepatitis (NASH)","volume":"1842","author":"Jha","year":"2014","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"10.1016\/j.jhep.2024.09.037_bib14","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.cmet.2024.03.011","article-title":"New and emerging treatments for metabolic dysfunction-associated steatohepatitis","volume":"36","author":"Tincopa","year":"2024","journal-title":"Cell Metab"},{"issue":"1","key":"10.1016\/j.jhep.2024.09.037_bib15","article-title":"Pharmacological inhibition of adipose triglyceride lipase corrects high-fat diet-induced insulin resistance and hepatosteatosis in mice","volume":"8","author":"Schweiger","year":"2017","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.jhep.2024.09.037_bib16","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/hep.32112","article-title":"Hepatocyte-specific deletion of adipose triglyceride lipase (adipose triglyceride lipase\/patatin-like phospholipase domain containing 2) ameliorates dietary induced steatohepatitis in mice","volume":"75","author":"Fuchs","year":"2022","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.jhep.2024.09.037_bib17","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1210\/en.2015-1322","article-title":"Impact of reduced ATGL-mediated adipocyte lipolysis on obesity-associated insulin resistance and inflammation in male mice","volume":"156","author":"Schoiswohl","year":"2015","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.jhep.2024.09.037_bib18","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.cell.2015.01.012","article-title":"Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes","volume":"160","author":"Perry","year":"2015","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.jhep.2024.09.037_bib19","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/hep.26732","article-title":"Role of adipose triglyceride lipase (PNPLA2) in protection from hepatic inflammation in mouse models of steatohepatitis and endotoxemia","volume":"59","author":"Jha","year":"2014","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.jhep.2024.09.037_bib20","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1038\/s41588-022-01199-5","article-title":"Multiomics study of nonalcoholic fatty liver disease","volume":"54","author":"Sveinbjornsson","year":"2022","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.jhep.2024.09.037_bib21","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00795-013-0016-1","article-title":"A murine model for non-alcoholic steatohepatitis showing evidence of association between diabetes and hepatocellular carcinoma","volume":"46","author":"Fujii","year":"2013","journal-title":"Med Mol Morphol"},{"issue":"3","key":"10.1016\/j.jhep.2024.09.037_bib22","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1194\/jlr.RA119000243","article-title":"A human-like bile acid pool induced by deletion of hepatic Cyp2c70 modulates effects of FXR activation in mice","volume":"61","author":"de Boer","year":"2020","journal-title":"J Lipid Res"},{"issue":"10","key":"10.1016\/j.jhep.2024.09.037_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108819","article-title":"Human gastrointestinal epithelia of the esophagus, stomach, and duodenum resolved at single-cell resolution","volume":"34","author":"Busslinger","year":"2021","journal-title":"Cell Rep"},{"issue":"105","key":"10.1016\/j.jhep.2024.09.037_bib24","doi-asserted-by":"crossref","DOI":"10.3791\/53359","article-title":"Organoids as model for infectious diseases: culture of human and murine stomach organoids and microinjection of Helicobacter pylori","author":"Bartfeld","year":"2015","journal-title":"J Vis Exp"},{"issue":"1","key":"10.1016\/j.jhep.2024.09.037_bib25","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/hep.25601","article-title":"Absence of adipose triglyceride lipase protects from hepatic endoplasmic reticulum stress in mice","volume":"56","author":"Fuchs","year":"2012","journal-title":"Hepatology"},{"issue":"14","key":"10.1016\/j.jhep.2024.09.037_bib26","doi-asserted-by":"crossref","first-page":"6237","DOI":"10.1021\/jacs.1c10836","article-title":"Small-molecule inhibitors targeting lipolysis in human adipocytes","volume":"144","author":"Grabner","year":"2022","journal-title":"J Am Chem Soc"},{"issue":"8","key":"10.1016\/j.jhep.2024.09.037_bib27","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.bbalip.2007.03.006","article-title":"PPARgamma in human and mouse physiology","volume":"1771","author":"Heikkinen","year":"2007","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"10.1016\/j.jhep.2024.09.037_bib28","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3727\/105221619X15529371970455","article-title":"Sterol 12\u03b1-hydroxylase aggravates dyslipidemia by activating the ceramide\/mTORC1\/SREBP-1C pathway via FGF21 and FGF15","volume":"19","author":"Pathak","year":"2019","journal-title":"Gene Expr"},{"issue":"12","key":"10.1016\/j.jhep.2024.09.037_bib29","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1194\/jlr.M071183","article-title":"Cyp2c70 is responsible for the species difference in bile acid metabolism between mice and humans","volume":"57","author":"Takahashi","year":"2016","journal-title":"J Lipid Res"},{"issue":"1","key":"10.1016\/j.jhep.2024.09.037_bib30","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cmet.2016.05.005","article-title":"Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism","volume":"24","author":"Wahlstr\u00f6m","year":"2016","journal-title":"Cell Metab"},{"issue":"2","key":"10.1016\/j.jhep.2024.09.037_bib31","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1194\/jlr.M031716","article-title":"Adipose triglyceride lipase is a TG hydrolase of the small intestine and regulates intestinal PPAR\u03b1 signaling","volume":"54","author":"Obrowsky","year":"2013","journal-title":"J Lipid Res"},{"issue":"1","key":"10.1016\/j.jhep.2024.09.037_bib32","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/hep.32538","article-title":"Intestinal peroxisome proliferator-activated receptor \u03b1-fatty acid-binding protein 1 axis modulates nonalcoholic steatohepatitis","volume":"77","author":"Yan","year":"2023","journal-title":"Hepatology"},{"issue":"37","key":"10.1016\/j.jhep.2024.09.037_bib33","doi-asserted-by":"crossref","first-page":"28947","DOI":"10.1074\/jbc.M002782200","article-title":"The peroxisome proliferator-activated receptor alpha (PPARalpha) regulates bile acid biosynthesis","volume":"275","author":"Hunt","year":"2000","journal-title":"J Biol Chem"},{"issue":"Pt 3","key":"10.1016\/j.jhep.2024.09.037_bib34","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1042\/bj3510747","article-title":"The effect of peroxisome-proliferator-activated receptor-alpha on the activity of the cholesterol 7 alpha-hydroxylase gene","volume":"351","author":"Patel","year":"2000","journal-title":"Biochem J"},{"issue":"11","key":"10.1016\/j.jhep.2024.09.037_bib35","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1161\/hq1101.098228","article-title":"Fibrates suppress bile acid synthesis via peroxisome proliferator\u2013activated receptor-\u03b1\u2013mediated downregulation of cholesterol 7\u03b1-hydroxylase and sterol 27-hydroxylase expression","volume":"21","author":"Post","year":"2001","journal-title":"Arteriosclerosis Thromb Vasc Biol"},{"issue":"3","key":"10.1016\/j.jhep.2024.09.037_bib36","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1053\/j.gastro.2019.05.057","article-title":"Intestinal PPAR\u03b1 protects against colon carcinogenesis via regulation of methyltransferases DNMT1 and PRMT6","volume":"157","author":"Luo","year":"2019","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.jhep.2024.09.037_bib37","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1210\/me.2003-0327","article-title":"The protein kinase C signaling pathway regulates a molecular switch between transactivation and transrepression activity of the peroxisome proliferator-activated receptor \u03b1","volume":"18","author":"Blanquart","year":"2004","journal-title":"Mol Endocrinol"},{"issue":"10","key":"10.1016\/j.jhep.2024.09.037_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110910","article-title":"ATGL-dependent white adipose tissue lipolysis controls hepatocyte PPAR\u03b1 activity","volume":"39","author":"Fougerat","year":"2022","journal-title":"Cell Rep"},{"issue":"11","key":"10.1016\/j.jhep.2024.09.037_bib39","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1194\/jlr.M010256","article-title":"CGI-58 knockdown in mice causes hepatic steatosis but prevents diet-induced obesity and glucose intolerance","volume":"51","author":"Brown","year":"2010","journal-title":"J lipid Res"},{"issue":"9","key":"10.1016\/j.jhep.2024.09.037_bib40","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/nm.2439","article-title":"ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-\u03b1 and PGC-1","volume":"17","author":"Haemmerle","year":"2011","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.jhep.2024.09.037_bib41","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12944-016-0194-7","article-title":"Free fatty acids, not triglycerides, are associated with non-alcoholic liver injury progression in high fat diet induced obese rats","volume":"15","author":"Liu","year":"2016","journal-title":"Lipids Health Dis"},{"issue":"7","key":"10.1016\/j.jhep.2024.09.037_bib42","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41575-021-00566-7","article-title":"Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology","volume":"19","author":"Fuchs","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.jhep.2024.09.037_bib43","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jhep.2015.02.019","article-title":"PPAR\u03b1 gene expression correlates with severity and histological treatment response in patients with non-alcoholic steatohepatitis","volume":"63","author":"Francque","year":"2015","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.jhep.2024.09.037_bib44","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.jacl.2018.08.003","article-title":"Effects of free omega-3 carboxylic acids and fenofibrate on liver fat content in patients with hypertriglyceridemia and non-alcoholic fatty liver disease: a double-blind, randomized, placebo-controlled study","volume":"12","author":"Oscarsson","year":"2018","journal-title":"J Clin Lipidol"},{"issue":"6","key":"10.1016\/j.jhep.2024.09.037_bib45","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1210\/jc.2009-2622","article-title":"Effect of fenofibrate and niacin on intrahepatic triglyceride content, very low-density lipoprotein kinetics, and insulin action in obese subjects with nonalcoholic fatty liver disease","volume":"95","author":"Fabbrini","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"17","key":"10.1016\/j.jhep.2024.09.037_bib46","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa2036205","article-title":"A randomized, controlled trial of the pan-PPAR agonist lanifibranor in NASH","volume":"385","author":"Francque","year":"2021","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jhep.2024.09.037_bib47","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1053\/j.gastro.2008.03.078","article-title":"Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled fatty liver improvement with rosiglitazone therapy (FLIRT) trial","volume":"135","author":"Ratziu","year":"2008","journal-title":"Gastroenterology"},{"issue":"18","key":"10.1016\/j.jhep.2024.09.037_bib48","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"362","author":"Sanyal","year":"2010","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.jhep.2024.09.037_bib49","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1007\/s00125-007-0698-9","article-title":"Effects of peroxisome proliferator-activated receptor (PPAR)-alpha and PPAR-gamma agonists on glucose and lipid metabolism in patients with type 2 diabetes mellitus","volume":"50","author":"Bajaj","year":"2007","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.jhep.2024.09.037_bib50","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1464-5491.2009.02906.x","article-title":"Combination peroxisome proliferator-activated receptor gamma and alpha agonist treatment in Type 2 diabetes prevents the beneficial pioglitazone effect on liver fat content","volume":"27","author":"Balasubramanian","year":"2010","journal-title":"Diabet Med"},{"key":"10.1016\/j.jhep.2024.09.037_bib51","article-title":"Fenofibrate enhances lipid deposition via modulating PPAR\u03b3, SREBP-1c, and gut microbiota in ob\/ob mice fed a high-fat diet","volume":"9","author":"Zhang","year":"2022","journal-title":"Front Nutr"},{"issue":"4","key":"10.1016\/j.jhep.2024.09.037_bib52","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1194\/jlr.M070631","article-title":"Fenofibrate, but not ezetimibe, prevents fatty liver disease in mice lacking phosphatidylethanolamine N-methyltransferase","volume":"58","author":"van der Veen","year":"2017","journal-title":"J Lipid Res"},{"issue":"3","key":"10.1016\/j.jhep.2024.09.037_bib53","doi-asserted-by":"crossref","first-page":"G262","DOI":"10.1152\/ajpgi.00129.2021","article-title":"PPAR\u03b1 agonist fenofibrate attenuates iron-induced liver injury in mice by modulating the Sirt3 and \u03b2-catenin signaling","volume":"321","author":"Mandala","year":"2021","journal-title":"Am J Physiology-Gastrointestinal Liver Physiol"},{"issue":"3","key":"10.1016\/j.jhep.2024.09.037_bib54","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jhep.2014.10.039","article-title":"Molecular mechanism of PPAR\u03b1 action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease","volume":"62","author":"Pawlak","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2024.09.037_bib55","article-title":"Therapeutic effect of fenofibrate for non-alcoholic steatohepatitis in mouse models is dependent on regime design","volume":"14","author":"Wang","year":"2023","journal-title":"Front Pharmacol"},{"issue":"40","key":"10.1016\/j.jhep.2024.09.037_bib56","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2205755119","article-title":"Circadian clock controls rhythms in ketogenesis by interfering with PPAR\u03b1 transcriptional network","volume":"119","author":"Mezhnina","year":"2022","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"10.1016\/j.jhep.2024.09.037_bib57","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0021-9258(20)78929-5","article-title":"On the nature and r\u00f4le of the fatty acids essential in nutrition","volume":"86","author":"Burr","year":"1930","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.jhep.2024.09.037_bib58","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1194\/jlr.R055095","article-title":"Discovery of essential fatty acids","volume":"56","author":"Spector","year":"2015","journal-title":"J Lipid Res"},{"issue":"2","key":"10.1016\/j.jhep.2024.09.037_bib59","first-page":"115","article-title":"Fatty acid regulation of hepatic lipid metabolism","volume":"14","author":"Jump","year":"2011","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"1","key":"10.1016\/j.jhep.2024.09.037_bib60","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2019-000871","article-title":"Hepatic de novo lipogenesis is suppressed and fat oxidation is increased by omega-3 fatty acids at the expense of glucose metabolism","volume":"8","author":"Green","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"43","key":"10.1016\/j.jhep.2024.09.037_bib61","doi-asserted-by":"crossref","first-page":"26827","DOI":"10.1074\/jbc.272.43.26827","article-title":"Polyunsaturated fatty acid suppression of hepatic fatty acid synthase and S14 gene expression does not require peroxisome proliferator-activated receptor alpha","volume":"272","author":"Ren","year":"1997","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.jhep.2024.09.037_bib62","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/embo-reports\/kve071","article-title":"Mechanisms of nutritional and hormonal regulation of lipogenesis","volume":"2","author":"Kersten","year":"2001","journal-title":"EMBO Rep"},{"issue":"5","key":"10.1016\/j.jhep.2024.09.037_bib63","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0022-2275(20)30110-3","article-title":"Suppression of fatty acid synthase promoter by polyunsaturated fatty acids","volume":"43","author":"Moon","year":"2002","journal-title":"J Lipid Res"},{"issue":"2","key":"10.1016\/j.jhep.2024.09.037_bib64","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.canlet.2004.11.031","article-title":"Regulation of HMG-CoA reductase in MCF-7 cells by genistein, EPA, and DHA, alone and in combination with mevastatin","volume":"224","author":"Duncan","year":"2005","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jhep.2024.09.037_bib65","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1476-511X-9-135","article-title":"Synergic effect of eicosapentaenoic acid and lovastatin on gene expression of HMGCoA reductase and LDL receptor in cultured HepG2 cells","volume":"9","author":"Notarnicola","year":"2010","journal-title":"Lipids Health Dis"},{"issue":"2","key":"10.1016\/j.jhep.2024.09.037_bib66","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1194\/jlr.P800013-JLR200","article-title":"The relationships of cholesterol metabolism and plasma plant sterols with the severity of coronary artery disease","volume":"50","author":"Silbernagel","year":"2009","journal-title":"J Lipid Res"},{"issue":"6","key":"10.1016\/j.jhep.2024.09.037_bib67","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/cr.2008.61","article-title":"Feedback regulation of cholesterol synthesis: sterol-accelerated ubiquitination and degradation of HMG CoA reductase","volume":"18","author":"DeBose-Boyd","year":"2008","journal-title":"Cell Res"},{"issue":"6","key":"10.1016\/j.jhep.2024.09.037_bib68","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1021\/acs.jproteome.5b00213","article-title":"A comparison of the mouse and human lipoproteome: suitability of the mouse model for studies of human lipoproteins","volume":"14","author":"Gordon","year":"2015","journal-title":"J Proteome Res"},{"issue":"8","key":"10.1016\/j.jhep.2024.09.037_bib69","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/S0022-2275(20)33384-8","article-title":"Conjugated linoleic acid is a potent naturally occurring ligand and activator of PPARalpha","volume":"40","author":"Moya-Camarena","year":"1999","journal-title":"J Lipid Res"},{"issue":"12","key":"10.1016\/j.jhep.2024.09.037_bib70","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1038\/s41591-019-0660-7","article-title":"Three-dimensional spatially resolved geometrical and functional models of human liver tissue reveal new aspects of NAFLD progression","volume":"25","author":"Segovia-Miranda","year":"2019","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.jhep.2024.09.037_bib71","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1136\/gut.2003.037689","article-title":"Bile secretory function in the obese Zucker rat: evidence of cholestasis and altered canalicular transport function","volume":"53","author":"Pizarro","year":"2004","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.jhep.2024.09.037_bib72","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1074\/jbc.M307363200","article-title":"Hepatic overexpression of murine Abcb11 increases hepatobiliary lipid secretion and reduces hepatic steatosis","volume":"279","author":"Figge","year":"2004","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.jhep.2024.09.037_bib73","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1053\/j.gastro.2011.06.062","article-title":"Hepatic overexpression of abcb11 promotes hypercholesterolemia and obesity in mice","volume":"141","author":"Henkel","year":"2011","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.jhep.2024.09.037_bib74","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1007\/s00535-015-1148-y","article-title":"The intrahepatic expression levels of bile acid transporters are inversely correlated with the histological progression of nonalcoholic fatty liver disease","volume":"51","author":"Okushin","year":"2016","journal-title":"J Gastroenterol"},{"issue":"6","key":"10.1016\/j.jhep.2024.09.037_bib75","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1111\/liv.14423","article-title":"Absence of Bsep\/Abcb11 attenuates MCD diet-induced hepatic steatosis but aggravates inflammation in mice","volume":"40","author":"Fuchs","year":"2020","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.jhep.2024.09.037_bib76","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.cmet.2013.01.003","article-title":"Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist","volume":"17","author":"Sayin","year":"2013","journal-title":"Cell Metab"},{"issue":"2","key":"10.1016\/j.jhep.2024.09.037_bib77","doi-asserted-by":"crossref","first-page":"E121","DOI":"10.1152\/ajpendo.00409.2016","article-title":"Cyp8b1 ablation prevents Western diet-induced weight gain and hepatic steatosis because of impaired fat absorption","volume":"313","author":"Bertaggia","year":"2017","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jhep.2024.09.037_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2021.100134","article-title":"Low production of 12\u03b1-hydroxylated bile acids prevents hepatic steatosis in Cyp2c70\u2212\/\u2212 mice by reducing fat absorption","volume":"62","author":"Li","year":"2021","journal-title":"J Lipid Res"},{"issue":"7","key":"10.1016\/j.jhep.2024.09.037_bib79","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1096\/fj.201701084RR","article-title":"Therapeutic modulation of the bile acid pool by Cyp8b1 knockdown protects against nonalcoholic fatty liver disease in mice","volume":"32","author":"Chevre","year":"2018","journal-title":"Faseb J"},{"issue":"7","key":"10.1016\/j.jhep.2024.09.037_bib80","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/gutjnl-2015-310798","article-title":"Liver PPAR\u03b1 is crucial for whole-body fatty acid homeostasis and is protective against NAFLD","volume":"65","author":"Montagner","year":"2016","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.jhep.2024.09.037_bib81","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cmet.2005.09.001","article-title":"Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis","volume":"2","author":"Inagaki","year":"2005","journal-title":"Cell Metab"},{"issue":"1","key":"10.1016\/j.jhep.2024.09.037_bib82","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cmet.2018.10.012","article-title":"Preclinical models for studying NASH-driven HCC: how useful are they?","volume":"29","author":"Febbraio","year":"2019","journal-title":"Cell Metab"},{"issue":"5","key":"10.1016\/j.jhep.2024.09.037_bib83","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127991","article-title":"Mouse models of diet-induced nonalcoholic steatohepatitis reproduce the heterogeneity of the human disease","volume":"10","author":"Machado","year":"2015","journal-title":"PLoS One"}],"updated-by":[{"DOI":"10.1016\/j.jhep.2025.08.003","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000}}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827824025777?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827824025777?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T12:10:50Z","timestamp":1778674250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827824025777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":83,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S0168827824025777"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2024.09.037","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of ATGL alleviates MASH via impaired PPAR\u03b1 signalling that favours hydrophilic bile acid composition in mice","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2024.09.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver.","name":"copyright","label":"Copyright"}]}}